Claudia Göpel; Jana Huster; Kerstin Klare; Heike Trefflich; Annemarie Michel; Bernhard Kiesel; Johannes Lange; R Schmidt adakia Verlag UG (2013) Kovakantinen kirja
Hamid R. Arabnia; Leonidas Deligiannidis; George Jandieri; Vince Schmidt; Ashu M. G. Solo; Fernando G. Tinetti C. S. R. E. A. (2014) Pehmeäkantinen kirja
K. Brück; W. Jänig; R. Rüdel; H. Schaefer; R. F. Schmidt; J. Schmier; M. Steinhausen; R. Taugner; V. Thämer; G. Thews Springer-Verlag Berlin and Heidelberg GmbH & Co. KG (1976) Pehmeäkantinen kirja
A. Defant; G. D. Birkhoff; W. Blaschke; R. Courant; R. Grammel; M. Morse; F. K. Schmidt; B. L. van der Waerden Springer Verlag GmbH (1929) Pehmeäkantinen kirja
G. Birnbaum; H. Boeminghaus; O. Dittrich; O. Fehr; R. Habermann; A. Kollmann; E. Langer; A. Morgenstern; E. Schmidt Springer-Verlag Berlin and Heidelberg GmbH & Co. KG (1930) Pehmeäkantinen kirja
E. Alberti; G. Angenheister; E. Gumlich; P. Hertz; W. Romanoff; R. Schmidt; W. Steinhaus; S. Valentiner; W. Westphal Springer-Verlag Berlin and Heidelberg GmbH & Co. KG (1927) Pehmeäkantinen kirja
Springer Sivumäärä: 260 sivua Asu: Kovakantinen kirja Painos: 2003 Julkaisuvuosi: 2003, 30.09.2003 (lisätietoa) Kieli: Englanti Tuotesarja:Falk Symposium 132
Development and progression of gastrointestinal disease involves inflammatory, vascular, fibrogenetic and immune reactions accompanied by deregulation of cellular growth and death often resulting in cancer of the organs affected. This book, the proceedings of Falk Symposium 132 on `Disease Progression and Carcinogenesis in the Gastrointestinal Tract', held in Freiburg, Germany, October 9-10, 2002, addresses these various cellular processes in five sections in order to build up a broad pathogenic concept of gastrointestinal disease, purposely going beyond organ-specific research. Each section combines experts in the various fields of molecular medicine together with clinical scientists in order to stimulate interdisciplinary discussion. In addition, clinical chapters focus on new findings in both diagnostics and therapeutics.